Synaptogenix Inc (SNPX)

[Cyosol]

If Biogen can get a $20 billion valuation for an MCI drug meant to slow the decline then I think $5 billion for reversing brain damage would be quite the steal.

Charge 500k patients $10k for a year long treatment and you'll make that money back in a year and enjoy another 15 or so years of growing revenues until the patents expire.

Confirmed results would be a black swan.